108 related articles for article (PubMed ID: 3611532)
21. High peritoneal residual volume decreases the efficiency of peritoneal dialysis.
Wang T; Cheng HH; Heimbürger O; Bergström J; Lindholm B
Kidney Int; 1999 May; 55(5):2040-8. PubMed ID: 10231469
[TBL] [Abstract][Full Text] [Related]
22. Influence of peritoneal dialysis solutions with glucose and amino acids on ingestive behavior in rats.
Mamoun AH; Anderstam B; Södersten P; Lindholm B; Bergström J
Kidney Int; 1996 May; 49(5):1276-82. PubMed ID: 8731091
[TBL] [Abstract][Full Text] [Related]
23. Amino acid solutions for CAPD: rationale and clinical experience.
Jones MR; Martis L; Algrim CE; Bernard D; Swartz R; Messana J; Bergström J; Lindholm B; Lim V; Serkes KD
Miner Electrolyte Metab; 1992; 18(2-5):309-15. PubMed ID: 1465081
[TBL] [Abstract][Full Text] [Related]
24. Effects of amino acid dialysate on appetite in CAPD patients.
Musk M; Anderson H; Oreopoulos D; Leiter L; Bargman J; Pettit J; Jones M
Adv Perit Dial; 1992; 8():153-6. PubMed ID: 1361775
[TBL] [Abstract][Full Text] [Related]
25. 1% amino acid peritoneal dialysate: single-cycle study in diabetic patients with end-stage renal disease.
Arfeen S; Goodship TH; Kirkwood A; Channon S; Ward MK
Am J Kidney Dis; 1994 Jan; 23(1):86-90. PubMed ID: 8285202
[TBL] [Abstract][Full Text] [Related]
26. Protein and amino acid metabolism in patients undergoing continuous ambulatory peritoneal dialysis (CAPD).
Lindholm B; Bergström J
Clin Nephrol; 1988; 30 Suppl 1():S59-63. PubMed ID: 3141094
[TBL] [Abstract][Full Text] [Related]
27. Kinetics of peritoneal dialysis in children: role of lymphatics.
Mactier RA; Khanna R; Moore H; Russ J; Nolph KD; Groshong T
Kidney Int; 1988 Jul; 34(1):82-8. PubMed ID: 3172639
[TBL] [Abstract][Full Text] [Related]
28. Neutral-pH peritoneal dialysis solution improves peritoneal function and decreases matrix metalloproteinase-2 (MMP-2) in patients undergoing continuous ambulatory peritoneal dialysis (CAPD).
Nishina M; Endoh M; Suzuki D; Tanabe R; Endoh H; Hirahara I; Sakai H
Clin Exp Nephrol; 2004 Dec; 8(4):339-43. PubMed ID: 15619033
[TBL] [Abstract][Full Text] [Related]
29. [Effect of zinc supplements on the nutritional status of patients undergoing continuous ambulatory peritoneal dialysis].
Munguía C; Paniagua R; Avila-Díaz M; Nava-Hernández J; Rodríguez E; Ventura Mde J; Amato D
Rev Invest Clin; 2003; 55(5):519-27. PubMed ID: 14968473
[TBL] [Abstract][Full Text] [Related]
30. The nutritional/metabolic and hormonal effects of 8 weeks of continuous ambulatory peritoneal dialysis with a 1% amino acid solution.
Arfeen S; Goodship TH; Kirkwood A; Ward MK
Clin Nephrol; 1990 Apr; 33(4):192-99. PubMed ID: 2190721
[TBL] [Abstract][Full Text] [Related]
31. Loss of zinc and selenium does not occur through peritoneal dialysis.
Sriram K; Abraham G
Nutrition; 2000; 16(11-12):1047-51. PubMed ID: 11118823
[TBL] [Abstract][Full Text] [Related]
32. Amino-acid-based dialysis solution changes leptinemia and leptin peritoneal clearance.
Grzegorzewska AE; Wiecek A; Mariak I; Kokot F
Adv Perit Dial; 2000; 16():7-14. PubMed ID: 11045252
[TBL] [Abstract][Full Text] [Related]
33. Differences in fluid and solute transport between diabetic and nondiabetic patients at the onset of CAPD.
Serlie MJ; Struijk DG; de Blok K; Krediet RT
Adv Perit Dial; 1997; 13():29-32. PubMed ID: 9360646
[TBL] [Abstract][Full Text] [Related]
34. Impact of peritoneal absorption of glucose on appetite, protein catabolism and survival in CAPD patients.
Davies SJ; Russell L; Bryan J; Phillips L; Russell GI
Clin Nephrol; 1996 Mar; 45(3):194-8. PubMed ID: 8706362
[TBL] [Abstract][Full Text] [Related]
35. Intraperitoneal production of erythropoietin with continuous ambulatory peritoneal dialysis.
Chandra M; Clemons G; Sahdev I; McVicar M; Bluestone P
Pediatr Nephrol; 1993 Jun; 7(3):281-3. PubMed ID: 8518099
[TBL] [Abstract][Full Text] [Related]
36. Modification of peritoneal ultrafiltration capacity in children undergoing peritoneal dialysis.
Drachman R; Niaudet P; Gagnadoux MF; Broyer M
Int J Pediatr Nephrol; 1985; 6(1):35-40. PubMed ID: 3997371
[TBL] [Abstract][Full Text] [Related]
37. [Alternative dialysis solutions in continuous ambulatory peritoneal dialysis].
Olszowska A; Baczyński D
Pol Merkur Lekarski; 1998 Nov; 5(29):307-9. PubMed ID: 10101509
[TBL] [Abstract][Full Text] [Related]
38. Plasma amino acid levels and amino acid losses during continuous ambulatory peritoneal dialysis.
Kopple JD; Blumenkrantz MJ; Jones MR; Moran JK; Coburn JW
Am J Clin Nutr; 1982 Sep; 36(3):395-402. PubMed ID: 7113946
[TBL] [Abstract][Full Text] [Related]
39. Effects of conventional versus biocompatible peritoneal dialysis solutions on peritoneal and systemic inflammation, malnutrition and atherosclerosis in CAPD patients.
Stankovic-Popovic V; Nesic V; Popovic D; Maksic D; Colic M; Vasilijic S; Vucinic Z; Milicic B; Radjen S; Dimkovic N
Clin Nephrol; 2011 Oct; 76(4):314-22. PubMed ID: 21955867
[TBL] [Abstract][Full Text] [Related]
40. Erythrocyte, plasma, urine and dialysate zinc levels in patients on continuous ambulatory peritoneal dialysis.
Beerbower KS; Raess BU
Am J Clin Nutr; 1985 Apr; 41(4):697-702. PubMed ID: 3984923
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
